Correlation Between Alphabet and Oncolytics Biotech

Can any of the company-specific risk be diversified away by investing in both Alphabet and Oncolytics Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alphabet and Oncolytics Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alphabet Inc CDR and Oncolytics Biotech, you can compare the effects of market volatilities on Alphabet and Oncolytics Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alphabet with a short position of Oncolytics Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alphabet and Oncolytics Biotech.

Diversification Opportunities for Alphabet and Oncolytics Biotech

-0.59

Correlation Coefficient

Alphabet  Oncolytics Biotech

Excellent diversification

The 3 months correlation between Alphabet and Oncolytics is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Alphabet Inc CDR and Oncolytics Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncolytics Biotech and Alphabet is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alphabet Inc CDR are associated (or correlated) with Oncolytics Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncolytics Biotech has no effect on the direction of Alphabet i.e., Alphabet and Oncolytics Biotech go up and down completely randomly.

Pair Corralation between Alphabet and Oncolytics Biotech

Assuming the 90 days trading horizon Alphabet Inc CDR is expected to generate 0.39 times more return on investment than Oncolytics Biotech. However, Alphabet Inc CDR is 2.58 times less risky than Oncolytics Biotech. It trades about 0.08 of its potential returns per unit of risk. Oncolytics Biotech is currently generating about -0.01 per unit of risk. If you would invest  1,686  in Alphabet Inc CDR on October 11, 2024 and sell it today you would earn a total of  1,557  from holding Alphabet Inc CDR or generate 92.35% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	99.8%
Values	Daily Returns

Alphabet Inc CDR  vs.  Oncolytics Biotech

Alphabet CDR

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Alphabet Inc CDR are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating technical and fundamental indicators, Alphabet exhibited solid returns over the last few months and may actually be approaching a breakup point.

Oncolytics Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncolytics Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in February 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Alphabet and Oncolytics Biotech

The main advantage of trading using opposite Alphabet and Oncolytics Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alphabet position performs unexpectedly, Oncolytics Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncolytics Biotech will offset losses from the drop in Oncolytics Biotech's long position.

The idea behind Alphabet Inc CDR and Oncolytics Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.